European life sciences investment group LSP said yesterday it closed its new $330 million (EU €280 million) medical technology fund. The new Health Economics Fund 2 was oversubscribed and exceeded its target size and original hard cap, LSP said. The investment group touted the fund as the largest in Europe to be dedicated to medical […]